PD-033Right-sided colon cancer is associated with increased frequency of KRAS mutation and with a poor outcome in patients with metastatic disease treated in the first line with bevacizumab and chemotherapy.
| Image |  |
|---|---|
| Description | scientific article published on 21 June 2016 |
| Author/s |
author: Lenka Zdrazilova-Dubska |
| Publication date | June 21, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |